Private Offering Of Senior Unsecured Notes Launched By Bristol-Myers Squibb

Bristol-Myers Squibb Company Announces Launch of Private Offering of Senior Unsecured Notes. The Offering is being conducted in connection with the previously announced proposed acquisition (the “Merger”) of Celgene Corporation (“Celgene”). Bristol-Myers Squibb expects to use the net proceeds from the Offering to fund a portion of the aggregate cash portion of the merger consideration to be paid to Celgene shareholders in connection with the Merger and to pay related fees and expenses, with any remaining proceeds being used for general corporate purposes.

Details:
businesswire.com/news/home/20190501006077/en/Bristol-Myers-Squibb-Company-Announces-Launch-Private-Offering